- All sections
- C - Chemistrymetallurgy
- C12R - Indexing scheme associated with subclasses , relating to microorganisms
- C12R 1/36 - Neisseria
Patent holdings for IPC class C12R 1/36
Total number of patents in this class: 21
10-year publication summary
|
0
|
2
|
2
|
3
|
3
|
0
|
1
|
1
|
0
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1646 |
5 |
| Pierre Fabre Dermo-Cosmetique | 368 |
4 |
| Mars, Incorporated | 2922 |
1 |
| Fundacao Oswaldo Cruz | 105 |
1 |
| Genetic Signatures Limited | 7 |
1 |
| Health Protection Agency | 27 |
1 |
| National University of Singapore | 2449 |
1 |
| Universite Pierre et Marie Curie (Paris 6) | 537 |
1 |
| University of Massachusetts Medical School | 67 |
1 |
| Sorbonne Universite | 1279 |
1 |
| Centre National de La Recherche Scientifique (cnrs) | 3113 |
1 |
| Shanghai Jiao Tong University School of Medicine | 33 |
1 |
| Chengdu Olymvax Biopharmaceutical Co.,Ltd | 12 |
1 |
| Intravacc B.V. | 26 |
1 |
| Other owners | 0 |